Sarcoidosis
1Department of Ophthalmology, hôpital Cochin, Assistance publique-Hôpitaux de Paris, université Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
Journal Francais D'Ophtalmologie
|November 20, 2018
Summary
Ocular sarcoidosis, an inflammatory eye condition, often presents as uveitis. Diagnosis can be challenging without systemic evidence, but treatment typically involves steroids or immunosuppressants.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Sarcoidosis is a systemic granulomatosis affecting multiple organs, commonly the lungs, skin, and eyes.
- Ophthalmological involvement occurs in 20-50% of sarcoidosis cases, often manifesting as granulomatous uveitis.
- Diagnosing ocular sarcoidosis can be difficult, especially when systemic involvement is not apparent.
Purpose of the Study:
- To review the diagnostic challenges and treatment strategies for ocular sarcoidosis.
- To highlight the typical clinical presentation of ocular sarcoidosis.
- To discuss current therapeutic options for managing ocular sarcoidosis.
Main Methods:
- Review of clinical, paraclinical, and histological findings in sarcoidosis diagnosis.
- Analysis of ophthalmological signs suggestive of ocular sarcoidosis.
- Evaluation of treatment responses to corticosteroids and immunosuppressants.
Main Results:
- Ocular sarcoidosis diagnosis often relies on clinical and histological evidence, sometimes requiring algorithms for isolated uveitis.
- Steroid-responsive uveitis is common, but corticosteroid-dependent cases necessitate further immunosuppression.
- Anti-tumor necrosis factor alpha agents offer an alternative for refractory ocular sarcoidosis.
Conclusions:
- Ocular sarcoidosis diagnosis requires a comprehensive approach, integrating systemic and ocular findings.
- Effective management of ocular sarcoidosis involves a stepwise therapeutic strategy, starting with steroids and progressing to immunosuppressants or biologics.
- Further research may elucidate the mechanisms behind isolated ocular sarcoidosis to improve diagnostic accuracy.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
